Sunny Pharmtech Issues Recall of Cyclophosphamide Injection Due to Contamination
Sunny Pharmtech is recalling Cyclophosphamide for Injection due to contamination with particulate matter identified as steel.
Asset / Drug
Drug and asset intelligence for Sunny with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
Chemotherapy
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.